$3.43
3.63% today
Nasdaq, Sep 23, 07:47 pm CET
ISIN
US59503A1051
Symbol
MBOT

Microbot Medical Inc Stock price

$3.31
-0.54 14.03% 1M
+1.71 106.88% 6M
+2.19 195.54% YTD
+2.46 289.41% 1Y
-2.16 39.49% 3Y
-4.02 54.84% 5Y
-855.29 99.61% 10Y
-84,074.69 100.00% 20Y
Nasdaq, Closing price Mon, Sep 22 2025
+0.12 3.76%

Key metrics

Basic
Market capitalization
$150.8m
Enterprise Value
$118.1m
Net debt
positive
Cash
$32.7m
Shares outstanding
38.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 90.7
EV/Sales
- | 71.0
EV/FCF
negative
P/B
5.0
Financial Health
Equity Ratio
58.5%
Return on Equity
-324.2%
ROCE
-43.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $1.7m
EBITDA
$-13.1m | -
EBIT
$-13.2m | $-14.0m
Net Income
$-12.7m | $-13.2m
Free Cash Flow
$-9.9m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-24.3% | -
EBIT
-24.0% | -20.3%
Net Income
-21.7% | -15.0%
Free Cash Flow
-25.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -791.6%
Free Cash Flow
-
More
EPS
$-0.3
FCF per Share
$-0.3
Short interest
15.6%
Employees
20
Rev per Employee
$0.0
Show more

Is Microbot Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Microbot Medical Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Microbot Medical Inc forecast:

Buy
86%
Hold
14%

Financial data from Microbot Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.86 5.86
40% 40%
-
- Research and Development Expense 7.61 7.61
43% 43%
-
-13 -13
24% 24%
-
- Depreciation and Amortization 0.08 0.08
20% 20%
-
EBIT (Operating Income) EBIT -13 -13
24% 24%
-
Net Profit -13 -13
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about Microbot Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Microbot Medical Inc Stock News

Neutral
GlobeNewsWire
about 6 hours ago
Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live
Neutral
GlobeNewsWire
7 days ago
$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in...
Neutral
GlobeNewsWire
8 days ago
BRAINTREE, Mass., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the entry into definitive agreements for the exercise of certain outstanding preferred investment options to purchase up to an aggregate of 13,989,115 shares of common stock.
More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office United States
CEO Harel Gadot
Employees 20
Founded 1988
Website www.microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today